EXTL3 Antibodies

Santa Cruz Biotechnology offers a broad range of EXTL3 monoclonal antibodies for research focused on understanding EXTL3 functions. EXTL3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EXTL3, or exostosin-like 3, is a glycosyltransferase involved in the biosynthesis of heparan sulfate, a critical component of the extracellular matrix. EXTL3 plays a significant role in cell signaling, development, and tissue homeostasis. Research has shown that EXTL3 expression changes can impact various cellular processes and pathways. Studying EXTL3 has become increasingly important due to its involvement in cancer progression and developmental disorders. Understanding EXTL3's molecular mechanisms can provide valuable insights into disease pathogenesis and potential therapeutic strategies. EXTL3 research continues to reveal new functions and regulatory mechanisms in different biological systems. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of EXTL3's role in health and disease.